Profile data is unavailable for this security.
About the company
LENSAR, Inc. is a commercial-stage medical device company. The Company is focused on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its product portfolio consists of the LENSAR Laser System and ALLY Adaptive Cataract Treatment System (ALLY System) and its associated consumable components. The system incorporates a range of technologies designed to assist the surgeon in obtaining visual outcomes. The consumable portion of the system consists of a disposable patient interface device kit. The ALLY System is designed to combine its femtosecond laser technology features with enhanced laser capabilities into a single small unit that allows surgeons to perform a femtosecond laser assisted cataract procedure in a single operating room or in-office surgical suite. Its system is used across surgeons, hospital outpatient surgical facilities and ambulatory surgery centers.
- Revenue in USD (TTM)45.12m
- Net income in USD-12.56m
- Incorporated2004
- Employees130.00
- LocationLENSAR Inc2800 Discovery Drive, Suite 100ORLANDO 32826United StatesUSA
- Fax+1 (302) 655-5049
- Websitehttps://www.lensar.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BioNano Genomics Inc | 36.58m | -204.10m | 36.12m | 344.00 | -- | 0.37 | -- | 0.9874 | -5.15 | -5.15 | 0.7496 | 1.14 | 0.1826 | 1.00 | 5.28 | 106,334.30 | -101.86 | -56.82 | -123.67 | -67.83 | 28.97 | 25.38 | -557.98 | -505.76 | 1.11 | -61.51 | 0.0455 | -- | 29.90 | 24.65 | -75.34 | -- | 38.51 | -- |
| Precision Optics Corporation Inc | 19.41m | -1.64m | 37.15m | 84.00 | -- | 3.15 | -- | 1.91 | -0.2706 | -0.2706 | 3.24 | 1.86 | 1.06 | 4.30 | 4.51 | 231,098.50 | -8.98 | -6.71 | -13.18 | -10.55 | 33.65 | 33.65 | -8.43 | -5.02 | 1.05 | -8.86 | 0.1982 | -- | 34.23 | 39.12 | 84.42 | -- | 19.39 | -- |
| Rapid Micro Biosystems Inc | 24.71m | -50.46m | 37.29m | 193.00 | -- | 0.3942 | -- | 1.51 | -1.17 | -1.17 | 0.5711 | 2.20 | 0.1778 | 1.33 | 5.58 | 128,036.30 | -36.30 | -- | -40.86 | -- | -14.22 | -- | -204.22 | -- | 4.62 | -- | 0.003 | -- | 31.44 | -- | 13.71 | -- | -- | -- |
| Apyx Medical Corp | 49.03m | -28.37m | 37.76m | 252.00 | -- | 2.56 | -- | 0.7702 | -0.8188 | -0.8188 | 1.42 | 0.4257 | 0.7672 | 1.82 | 3.96 | 194,567.50 | -44.55 | -25.24 | -58.21 | -29.97 | 61.90 | 66.11 | -58.08 | -46.00 | 4.45 | -7.79 | 0.693 | -- | 17.61 | 25.82 | 19.28 | -- | 7.99 | -- |
| T2 Biosystems Inc | 7.16m | -48.26m | 38.46m | 113.00 | -- | -- | -- | 5.37 | -10.70 | -10.70 | 1.09 | -0.3391 | 0.2435 | 2.82 | 5.41 | 63,398.23 | -164.01 | -106.01 | -- | -253.03 | -86.96 | -12.60 | -673.67 | -317.93 | 0.359 | -12.44 | 2.00 | -- | -67.75 | -7.29 | 19.66 | -- | -20.19 | -- |
| electroCore, Inc. | 21.28m | -14.23m | 38.69m | 68.00 | -- | 3.37 | -- | 1.82 | -2.19 | -2.19 | 3.25 | 1.78 | 1.16 | 1.41 | 54.85 | 312,955.90 | -77.78 | -70.73 | -125.05 | -88.96 | 83.61 | 75.81 | -66.84 | -352.82 | 2.12 | -- | 0.00 | -- | 86.57 | 74.42 | 15.02 | -- | -5.88 | -- |
| Co-Diagnostics Inc | 9.14m | -37.57m | 40.53m | 155.00 | -- | 0.5598 | -- | 4.44 | -1.27 | -1.27 | 0.3077 | 2.27 | 0.0944 | 1.19 | 11.08 | 58,948.20 | -38.83 | 5.77 | -41.04 | 6.15 | 59.83 | 82.24 | -411.19 | 10.94 | 8.81 | -- | 0.00 | 0.00 | -80.09 | 179.54 | -148.15 | -- | 101.27 | -- |
| iCAD Inc | 18.80m | -4.54m | 41.40m | 67.00 | -- | 1.33 | -- | 2.20 | -0.1735 | -0.088 | 0.7185 | 1.17 | 0.4488 | 1.06 | 3.14 | 280,537.30 | -10.84 | -23.94 | -13.90 | -34.14 | 86.04 | 76.96 | -24.16 | -45.02 | 4.13 | -- | 0.00 | -- | -12.54 | -7.53 | 29.32 | -- | 23.88 | -- |
| Lucid Diagnostics Inc | 3.80m | -54.15m | 44.20m | 70.00 | -- | -- | -- | 11.63 | -1.23 | -1.23 | 0.0857 | 0.3238 | 0.0992 | -- | 38.97 | 54,285.71 | -121.82 | -- | -274.96 | -- | -67.39 | -- | -1,227.76 | -- | 1.71 | -- | 0.4178 | -- | 544.03 | -- | 6.24 | -- | -- | -- |
| LENSAR Inc | 45.12m | -12.56m | 50.03m | 130.00 | -- | 2.10 | -- | 1.11 | -1.11 | -1.11 | 3.92 | 3.24 | 0.6806 | 1.25 | 9.08 | 347,107.70 | -18.94 | -30.97 | -22.49 | -36.94 | 49.87 | 51.04 | -27.83 | -52.30 | 2.15 | -- | 0.00 | -- | 19.25 | 11.57 | 27.77 | -- | -42.91 | -- |
| Adagio Medical Holdings Inc | 0.00 | -2.54m | 54.35m | -- | -- | 1.36 | -- | -- | -0.1856 | -0.1856 | 0.00 | 2.99 | 0.00 | -- | -- | -- | -6.73 | -- | -9.12 | -- | -- | -- | -- | -- | -- | -- | 0.1226 | -- | -- | -- | -299.85 | -- | -- | -- |
| Heartbeam Inc | 0.00 | -16.91m | 56.31m | 15.00 | -- | 6.47 | -- | -- | -0.6375 | -0.6375 | 0.00 | 0.3278 | 0.00 | -- | -- | 0.00 | -106.50 | -- | -113.62 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -12.94 | -- | -- | -- |
| Medinotec Inc | 6.93m | -339.77k | 58.67m | 35.00 | -- | -- | -- | 8.46 | -0.029 | -0.029 | 0.5907 | 0.1918 | 1.54 | 5.36 | 23.11 | 198,040.90 | -7.54 | -- | -8.32 | -- | 44.05 | -- | -4.90 | -- | 3.86 | 3.97 | 0.3601 | -- | 402.25 | -- | -14.73 | -- | -- | -- |
| Pheton Holdings Ltd | 628.59k | -241.22k | 60.56m | 11.00 | -- | 166.52 | -- | 96.35 | -0.0201 | -0.0201 | 0.0524 | 0.0255 | -- | -- | -- | 57,144.55 | -- | -- | -- | -- | 74.90 | -- | -38.37 | -- | 0.3984 | -- | 0.00 | -- | -7.53 | -- | -387.24 | -- | -- | -- |
| Nutriband Inc | 1.80m | -7.24m | 62.14m | 13.00 | -- | 4.99 | -- | 34.45 | -0.8122 | -0.8122 | 0.1984 | 1.12 | 0.1535 | 6.29 | 12.38 | -- | -61.64 | -55.21 | -67.30 | -66.74 | 33.62 | 33.32 | -401.62 | -315.87 | 6.36 | -- | 0.0156 | -- | 0.2741 | 53.43 | -22.35 | -- | 65.57 | -- |
| Envoy Medical Inc | 302.00k | -16.27m | 62.52m | 34.00 | -- | -- | -- | 207.03 | -0.7683 | -0.7683 | 0.0172 | -0.632 | 0.0647 | 0.5686 | 2.64 | 8,882.35 | -290.14 | -- | -- | -- | -171.85 | -- | -4,481.79 | -- | 0.4237 | -38.98 | -- | -- | 33.33 | -- | -87.83 | -- | -- | -- |
Data as of Sep 20 2024. Currency figures normalised to LENSAR Inc's reporting currency: US Dollar USD
38.85%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| North Run Capital LPas of 07 May 2024 | 1.10m | 9.48% |
| Park West Asset Management LLCas of 30 Jun 2024 | 973.41k | 8.39% |
| Dimensional Fund Advisors LPas of 30 Jun 2024 | 642.03k | 5.53% |
| The Vanguard Group, Inc.as of 30 Jun 2024 | 430.30k | 3.71% |
| Brandes Investment Partners LPas of 30 Jun 2024 | 373.20k | 3.22% |
| Renaissance Technologies LLCas of 30 Jun 2024 | 327.05k | 2.82% |
| DCF Capital LLCas of 30 Jun 2024 | 241.48k | 2.08% |
| Clearline Capital LPas of 30 Jun 2024 | 173.00k | 1.49% |
| BlackRock Fund Advisorsas of 30 Jun 2024 | 151.21k | 1.30% |
| Geode Capital Management LLCas of 30 Jun 2024 | 97.01k | 0.84% |
More ▼
Data from 07 May 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
